Novartis in dock over Diovan activities in Japan

15th January 2014

Novartis’ marketing practices in Japan are under the spotlight after the country’s health ministry called for a criminal investigation into the way the Swiss major has promoted its blood pressure blockbuster Diovan.

The ministry has filed a formal criminal complaint with the Tokyo public prosecutor’s office in response to alleged misleading advertising

Read more at source www.pharmatimes.com


Leave a Reply

Your email address will not be published.

65 + = 74

« back to posts